Genetically modified NSCs expressing Aβ-degrading enzyme neprilysin in 3xTg-AD and Thy1-APP transgenic AD mice models exhibited significant reduction in Aβ pathology and increase in synaptic density [21]. This evidence concerns the gene MME and Alzheimer disease.